BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8861619)

  • 1. Interactions between excitotoxins and the Na+/K+-ATPase inhibitor ouabain in causing neuronal lesions in the rat hippocampus.
    Lees GJ; Leong W
    Brain Res; 1996 Apr; 714(1-2):145-55. PubMed ID: 8861619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ; Leong W
    Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus.
    Kawamoto EM; Lima LS; Munhoz CD; Yshii LM; Kinoshita PF; Amara FG; Pestana RR; Orellana AM; Cipolla-Neto J; Britto LR; Avellar MC; Rossoni LV; Scavone C
    J Neurosci Res; 2012 Jan; 90(1):213-28. PubMed ID: 22006678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na
    Kurauchi Y; Noma K; Hisatsune A; Seki T; Katsuki H
    J Pharmacol Sci; 2018 Nov; 138(3):167-175. PubMed ID: 30322800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine preconditions against ouabain but not against glutamate on CA1-evoked potentials in rat hippocampal slices.
    Ferguson AL; Stone TW
    Eur J Neurosci; 2008 Nov; 28(10):2084-98. PubMed ID: 19046389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo excitotoxicity induced by ouabain, a Na+/K+-ATPase inhibitor.
    Veldhuis WB; van der Stelt M; Delmas F; Gillet B; Veldink GA; Vliegenthart JF; Nicolay K; Bär PR
    J Cereb Blood Flow Metab; 2003 Jan; 23(1):62-74. PubMed ID: 12500092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in the rat hippocampus.
    Lees GJ; Lehmann A; Sandberg M; Hamberger A
    Neurosci Lett; 1990 Dec; 120(2):159-62. PubMed ID: 1705675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na+,K+-ATPase functionally interacts with the plasma membrane Na+,Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress.
    Sibarov DA; Bolshakov AE; Abushik PA; Krivoi II; Antonov SM
    J Pharmacol Exp Ther; 2012 Dec; 343(3):596-607. PubMed ID: 22927545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro.
    Nanitsos EK; Acosta GB; Saihara Y; Stanton D; Liao LP; Shin JW; Rae C; Balcar VJ
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):762-9. PubMed ID: 15566390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Iminothiazolidine-4-carboxylic acid produces hippocampal CA1 lesions independent of seizure excitation and glutamate receptor activation.
    Bitner RS; Yim GK; Isom GE
    Neurotoxicology; 1997; 18(1):191-200. PubMed ID: 9216001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine increases hippocampal Na(+),K(+)-ATPase activity via NMDA-calcineurin pathway.
    Rambo LM; Ribeiro LR; Schramm VG; Berch AM; Stamm DN; Della-Pace ID; Silva LF; Furian AF; Oliveira MS; Fighera MR; Royes LF
    Brain Res Bull; 2012 Sep; 88(6):553-9. PubMed ID: 22742935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of [3H]dizocilpine binding to N-methyl-D-aspartate receptor by an endogenous Na+, K+-ATPase inhibitor: dependence on receptor activation.
    Reinés A; Peña C; Rodríguez de Lores Arnaiz G
    Brain Res; 2004 Jan; 996(1):117-25. PubMed ID: 14670638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabotropic glutamate receptor agonist 1S,3R-ACPD stimulates and modulates NMDA receptor mediated excitotoxicity in organotypic hippocampal slice cultures.
    Blaabjerg M; Kristensen BW; Bonde C; Zimmer J
    Brain Res; 2001 Apr; 898(1):91-104. PubMed ID: 11292452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo.
    Golden WC; Martin LJ
    Neuroscience; 2006; 137(1):133-44. PubMed ID: 16297565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.
    Bersier MG; Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Res; 2008 Jan; 33(1):66-72. PubMed ID: 17680361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/Kainate receptors in organotypic hippocampal cultures.
    Vornov JJ; Tasker RC; Park J
    Exp Neurol; 1995 May; 133(1):7-17. PubMed ID: 7541369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW; Noraberg J; Zimmer J
    Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate receptor involvement in phosphoinositide hydrolysis stimulation by an endogenous Na(+), K(+)-ATPase inhibitor and ouabain in neonatal rat brain.
    Calviño MA; Peña C; Rodríguez de Lores Arnaiz G
    Brain Res Dev Brain Res; 2002 Oct; 138(2):167-75. PubMed ID: 12354644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.